Idiopathic cardiomyopathies in Korean children. - 9-Year Korean Multicenter Study-

Jin Hee Oh1, Young Mi Hong, Jae Young Choi

  • 1Department of Pediatrics, The Catholic University of Korea, Seoul, Korean.

Insights

This study reports the epidemiology of childhood cardiomyopathies (CMPs) in Korea, finding an annual occurrence of 0.28 per 100,000 children. Dilated CMP was the most common type, with varying survival rates among subtypes.

Area of Science:

  • Pediatric Cardiology
  • Epidemiology
  • Cardiovascular Diseases

Background:

  • Idiopathic cardiomyopathies (CMPs) are a heterogeneous group of heart muscle diseases.
  • Epidemiologic data on CMPs are crucial for advancing therapeutic strategies.
  • Limited data exist on CMPs in Asian children, necessitating regional studies.

Purpose of the Study:

  • To conduct a retrospective epidemiologic study of primary cardiomyopathies in Korean children.
  • To determine the incidence and prevalence of different CMP subtypes in this population.
  • To analyze survival rates for various CMP classifications in children.

Main Methods:

  • A multicenter survey was conducted from January 1998 to December 2006.
  • Data were collected from 17 cardiovascular centers in Korea.
  • Patients were classified according to the American Heart Association's 2006 CMP classification.

Main Results:

  • A total of 277 primary CMP patients were identified among Korean children.
  • The average annual occurrence of new CMP cases was 0.28 per 100,000 children (<15 years).
  • Dilated CMP (DCMP) was the most prevalent (66.43%), followed by hypertrophic CMP (HCMP) (23.47%) and restrictive CMP (RCMP) (6.50%).
  • The point prevalence of primary CMP was estimated at 2.11/100,000 children.
  • Nine-year survival rates were 69.8% for DCMP, 90.3% for HCMP, and 47.2% for RCMP.

Conclusions:

  • The recent point prevalence of childhood primary CMP in Korea is estimated at 2.11/100,000.
  • Dilated CMP is the most common subtype in Korean children.
  • Further nationwide epidemiologic studies are recommended to refine these findings.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...